Events2Join

BioPharma Dive on X


BioPharma Dive (@BioPharmaDive) / X

We provide in-depth insight into the most significant news and trends shaping biotech and pharma. Sign up here: https://t.co/sTgs1kxwYE.

Biotech and Pharma Industry News - BioPharma Dive

BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development ...

Biotech and Pharma Industry News | BioPharma Dive

BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development ...

Biotech and Pharma Press Releases - BioPharma Dive

X-Therma, Inc. logo. X-Therma Announces World's First Subzero Transatlantic Organ Transports. Press release from X-Therma, Inc. • October 23, 2024. Enhancing ...

BioPharma Dive (@BioPharmaDive) / X

Join us for our event Biotech's New Normal: Challenges and Opportunities. We'll discuss the emerging biotech ecosystem with executives, venture investors ...

Biotech and Pharma Industry News - BioPharma Dive

We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more ... X-Therma, Inc. logo. X-Therma ...

BioPharma Dive on X: "Join the editorial team of BioPharma Dive for ...

Join the editorial team of BioPharma Dive for a live virtual event where we will explore the financial and operational challenges facing ...

Biotech and Pharma Industry News | BioPharma Dive

We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more ... X-Therma, Inc. logo. X-Therma ...

Biotech M&A has plateaued. Track the deals that are happening here.

BioPharma Dive is tracking M&A activity below. The database, which shows drugmaker buyouts that have happened since 2018 and were valued at $50 million or more ...

Want better cancer treatments? Make biopharma more like Silicon ...

BioPharma Dive reporter Gwendolyn Wu and Johnson & Johnson ... A photo of Jeff Jonas, CEO of biotech incubator Abio-X. Dec 06, 2022.

Biotech: Page 31 - BioPharma Dive

In an interview with BioPharma Dive, the longtime industry executive discussed becoming a biotech investor and his plans for Abio-X, a new incubator with $150 ...

Biopharma Consulting and Strategy Services | BCG

BCG X partnered with a global pharmaceutical company to launch a platform ... The Disease Deep Dive Navigator data-mining tool provides up-to-date ...

Biotech's New Normal | Event by BioPharma Dive

In this virtual event, BioPharma Dive journalists will discuss the emerging biotech ecosystem with executives, venture investors and industry experts.

X-Therma Announces World's First Subzero Transatlantic ... - LinkedIn

BioPharma Dive features a groundbreaking moment for organ preservation: X-Therma has achieved the world's first subzero transatlantic organ ...

Fierce Pharma Biopharma News & Insights

Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and ...

Bristol Myers Squibb: Global Biopharmaceutical Company

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious ...

3 major consumer groups driving efficacy for retail pharmacies

YouGov x BioPharma Dive playbook. 3 major consumer groups driving efficacy for retail pharmacies. Download the full report. As retail pharmacies double down on ...

Pfizer: One of the world's premier biopharmaceutical companies

Discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.

Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site

Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.

Recursion: Pioneering TechBio Solutions in Drug Discovery

Dive into Recursion's innovative approach to decoding biology. Join our mission, explore the future of TechBio, and be part of the revolution.